SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-326875
Filing Date
2013-08-08
Accepted
2013-08-08 16:17:20
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d576663d10q.htm 10-Q 771032
2 EX-10.1 d576663dex101.htm EX-10.1 32460
3 EX-31.1 d576663dex311.htm EX-31.1 6716
4 EX-31.2 d576663dex312.htm EX-31.2 6490
5 EX-32 d576663dex32.htm EX-32 4124
  Complete submission text file 0001193125-13-326875.txt   11044903

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dndn-20130630.xml EX-101.INS 1464652
7 XBRL TAXONOMY EXTENSION SCHEMA dndn-20130630.xsd EX-101.SCH 48688
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dndn-20130630_cal.xml EX-101.CAL 52170
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dndn-20130630_def.xml EX-101.DEF 126564
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dndn-20130630_lab.xml EX-101.LAB 381032
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dndn-20130630_pre.xml EX-101.PRE 292673
Mailing Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101
Business Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101 206-219-7815
DENDREON CORP (Filer) CIK: 0001107332 (see all company filings)

IRS No.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35546 | Film No.: 131022421
SIC: 2834 Pharmaceutical Preparations